Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version-Reference-Cited by-同舟云学术

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version

Published:2016-03-18 Issue:6 Volume:103 Page:686-692
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Masaki Yasufumi,Kawabata Hiroshi,Takai Kazue,Kojima Masaru,Tsukamoto Norifumi,Ishigaki Yasuhito,Kurose Nozomu,Ide Makoto,Murakami Jun,Nara Kenji,Yamamoto Hiroshi,Ozawa Yoko,Takahashi Hidekazu,Miura Katsuhiro,Miyauchi Tsutomu,Yoshida Shinichirou,Momoi Akihito,Awano Nobuyasu,Ikushima Soichiro,Ohta Yasunori,Furuta Natsue,Fujimoto Shino,Kawanami Haruka,Sakai Tomoyuki,Kawanami Takafumi,Fujita Yoshimasa,Fukushima Toshihiro,Nakamura Shigeo,Kinoshita Tomohiro,Aoki Sadao

Funder

the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare (MHLW) of Japan

the Japanese Ministry of Education, Culture, Sports, Science and Technology

the Kanazawa Medical University Research Foundation

Assist KAKEN from Kanazawa Medical University

Grant for Project Research from High-Tech Research Center of Kanazawa Medical University

Grant for Alumni Research(A) from Kanazawa Medical University

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-016-1979-1.pdf

Reference17 articles.

1. Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki. 2010;51:320–5 (in Japanese).

2. Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, Kobayashi S, et al. Multicentric Castleman’s disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus. 2011;20:44–50.

3. Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, et al. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013;53:57–61.

4. Takai K, Nikkuni K, Momoi A, Nagai K, Igarashi N, Saeki T. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases. J Clin Exp Hematop. 2013;53:63–8.

5. Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, et al. Clinical features and treatment of multicentric Castleman’s disease: a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop. 2013;53:69–77.

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Elusive Diagnosis of Castleman Disease;Annals of Thoracic Surgery Short Reports;2024-09

2. Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report;Modern Rheumatology Case Reports;2024-08-23

3. Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome;Internal Medicine;2024-07-01

4. TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly;Biomedicines;2024-06-08

5. TAFRO Syndrome on 18F-FDG-PET/CT: An Appealing Diagnostic Tool;Diagnostics;2024-05-16